CRA was engaged by a leading global health products company to perform a global transfer pricing planning study. The study involved the benchmarking and documentation of over 10 different types of transactions, including: marketing intangibles, technology intangibles, procurement services, contract R&D services, contract manufacturing services, distribution of raw materials, distribution of finished goods, and various types of operational services. The benchmarking analyses addressed operations in various geographic areas, including: North America, Europe and Asia-Pacific.
Drug pricing rules and tariffs reshape transfer pricing for IP
In the article “Drug Pricing Rules and Tariffs Reshape Transfer Pricing for IP,” published in Bloomberg Tax, CRA’s Transfer Pricing experts Robin Hart and ...